229 related articles for article (PubMed ID: 36872421)
1. Blood pressure response to exercise in unaffected relatives of autosomal dominant polycystic kidney disease patients: an observational study.
Yenigun EC; Turgut D; Cevher SK; Yucel C; Aypak C; Dede F
Int Urol Nephrol; 2023 Sep; 55(9):2313-2319. PubMed ID: 36872421
[TBL] [Abstract][Full Text] [Related]
2. Exercise capacity in polycystic kidney disease.
Reinecke NL; Cunha TM; Heilberg IP; Higa EM; Nishiura JL; Neder JA; Almeida WS; Schor N
Am J Kidney Dis; 2014 Aug; 64(2):239-46. PubMed ID: 24787761
[TBL] [Abstract][Full Text] [Related]
3. Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state.
Martinez-Vea A; Bardaj A; Gutierrez C; Garca C; Peralta C; Marcas L; Oliver JA
Am J Kidney Dis; 2004 Aug; 44(2):216-23. PubMed ID: 15264179
[TBL] [Abstract][Full Text] [Related]
4. Impairment of heart rate recovery index in autosomal-dominant polycystic kidney disease patients without hypertension.
Orscelik O; Kocyigit I; Baran O; Kaya C; Dogdu O; Zengin H; Karadavut S; Gedikli O; Kut E; Duran M; Calapkorur B; Tokgoz B; Kaya MG
Blood Press; 2012 Oct; 21(5):300-5. PubMed ID: 22545873
[TBL] [Abstract][Full Text] [Related]
5. Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
Sans L; Pascual J; Radosevic A; Quintian C; Ble M; Molina L; Mojal S; Ballarin JA; Torra R; Fernández-Llama P
Medicine (Baltimore); 2016 Dec; 95(49):e5595. PubMed ID: 27930582
[TBL] [Abstract][Full Text] [Related]
6. [Arterial blood pressure behavior during progressive muscular exercise in subjects with stable arterial hypertension].
Seguro C; Sau F; Zedda N; Scano G; Cherchi A
Cardiologia; 1991 Nov; 36(11):867-77. PubMed ID: 1817759
[TBL] [Abstract][Full Text] [Related]
7. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
[TBL] [Abstract][Full Text] [Related]
8. Central blood pressure and measures of early vascular disease in children with ADPKD.
Marlais M; Rajalingam S; Gu H; Savis A; Sinha MD; Winyard PJ
Pediatr Nephrol; 2019 Oct; 34(10):1791-1797. PubMed ID: 31243534
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute moderate-intensity exercise at different duration on blood pressure and endothelial function in young male patients with stage 1 hypertension.
Yan Y; Wang Z; Wang Y; Li X
Clin Exp Hypertens; 2021 Nov; 43(8):691-698. PubMed ID: 34225535
[TBL] [Abstract][Full Text] [Related]
10. Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome.
Tekin G; Tekin A; Kiliçarslan EB; Haydardedeoğlu B; Katircibaşi T; Koçum T; Erol T; Cölkesen Y; Sezgin AT; Müderrisoğlu H
Int J Cardiol; 2008 Oct; 130(1):49-55. PubMed ID: 18055040
[TBL] [Abstract][Full Text] [Related]
11. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.
Barrett BJ; Foley R; Morgan J; Hefferton D; Parfrey P
Kidney Int; 1994 Oct; 46(4):1118-23. PubMed ID: 7861706
[TBL] [Abstract][Full Text] [Related]
12. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
[TBL] [Abstract][Full Text] [Related]
13. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.
Heffernan KS; Kuvin JT; Sarnak MJ; Perrone RD; Miskulin DC; Rudym D; Chandra P; Karas RH; Menon V
Nephrol Dial Transplant; 2011 Aug; 26(8):2515-21. PubMed ID: 21292815
[TBL] [Abstract][Full Text] [Related]
14. Association of kidney and cysts dimensions with anthropometric and biochemical parameters in patients with ADPKD.
Pietrzak-Nowacka M; Safranow K; Palacz J; Gołembiewska E; Marchelek-Myśliwiec M; Ciechanowski K
Ren Fail; 2015 Jun; 37(5):798-803. PubMed ID: 25869055
[TBL] [Abstract][Full Text] [Related]
15. Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease.
Rahbari-Oskoui FF; Miskulin DC; Hogan MC; Fielder O; Torres VE; Bost JE; Chapman AB
Blood Press Monit; 2011 Apr; 16(2):47-54. PubMed ID: 21415814
[TBL] [Abstract][Full Text] [Related]
16. Screening of QTc interval and global autonomic activity in autosomal dominant polycystic kidney disease and atherosclerotic renal artery stenosis hypertensive patients.
Lai S; Perrotta AM; Bagordo D; Mazzaferro S; Menè P; Gigante A; Tinti F; Galani A; Cianci R
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6333-6338. PubMed ID: 34730214
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid Antagonism and Vascular Function in Early Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Trial.
Nowak KL; Gitomer B; Farmer-Bailey H; Wang W; Malaczewski M; Klawitter J; You Z; George D; Patel N; Jovanovich A; Chonchol M
Am J Kidney Dis; 2019 Aug; 74(2):213-223. PubMed ID: 30803706
[TBL] [Abstract][Full Text] [Related]
18. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O
Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725
[TBL] [Abstract][Full Text] [Related]
19. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner.
Pietrzak-Nowacka M; Safranow K; Czechowska M; Dutkiewicz G; Kornacewicz-Jach Z; Ciechanowski K
Kidney Blood Press Res; 2012; 36(1):301-9. PubMed ID: 23235185
[TBL] [Abstract][Full Text] [Related]
20. Morning blood pressure surge in early autosomal dominant polycystic kidney disease and its relation with left ventricular hypertrophy.
Yildiz A; Sag S; Gul CB; Güllülü S; Can FE; Bedir Ö; Aydin MF; Oruç A; Demirel S; Akgür S; Güllülü M; Ersoy A
Ren Fail; 2021 Dec; 43(1):223-230. PubMed ID: 33478355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
